A multicentre, randomised, double blind, parallel group, placebo controlled variable treatment duration study evaluating the efficacy and safety of Piponimod (BAF312) in patients with secondary

Project: Research

Project Details

StatusFinished
Effective start/end date18/02/13 → 29/05/14